Skip to main content
Top
Published in: Annals of Surgical Oncology 11/2013

01-10-2013 | Colorectal Cancer

Early Outcomes for Rectal Cancer Surgery in the Republic of Ireland Following a National Centralization Program

Authors: John P. Burke, PhD, MRCSI, J. Calvin Coffey, PhD, FRCSI, Emily Boyle, MD, MRCSI, Frank Keane, MCh, FRCSI, Deborah A. McNamara, MD, FRCSI

Published in: Annals of Surgical Oncology | Issue 11/2013

Login to get access

Abstract

Background

Following a national audit of rectal cancer management in 2007, a national centralization program in the Republic of Ireland was initiated. In 2010, a prospective evaluation of rectal cancer treatment and early outcomes was conducted.

Methods

A total of 29 colorectal surgeons in 14 centers prospectively collated data on all patients with rectal cancer who underwent curative surgery in 2010.

Results

Data were available on 447 patients who underwent proctectomy with curative intent for rectal cancer in 2010; 23.7 % of patients underwent abdominoperineal excision. The median number of lymph nodes identified was 12. The 30-day mortality rate was 1.1 %. Compared with 2007, there was a reduction in positive circumferential margin rate (15.8 vs 4.5 %, P < 0.001), clinical anastomotic leak rate (10.8 vs 4.3 %, P = 0.002), and postoperative radiotherapy use (17.8 vs 4.0 %, P < 0.001). Also, 53.9 % received preoperative radiotherapy in 2010. Four centers gave statistically more patients (high-administration), and four centers gave fewer patients (low-administration) preoperative radiotherapy for T2/T3 tumors (P < 0.05). On multivariate analysis, being treated in a “high-administration center” increased the likelihood (likelihood ratio [LR], 2.9; 95 % CI 1.7–4.8; P < 0.001) while attending a “low-administration center” (LR, 0.3; 95 % CI 0.2–0.5; P < 0.001) reduced the likelihood of receiving preoperative radiotherapy for a T2/T3 rectal cancer.

Conclusions

Patients undergoing rectal cancer surgery in hospitals following a national centralization initiative received high-quality surgery. Significant heterogeneity exists in radiotherapy administration, and evidence-based guidelines should be developed and implemented.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142–9.PubMedCrossRef Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142–9.PubMedCrossRef
2.
go back to reference Kee F, Wilson RH, Harper C, Patterson CC, McCallion K, Houston RF, et al. Influence of hospital and clinician workload on survival from colorectal cancer: cohort study. BMJ. 1999;318:1381–5.PubMedCrossRef Kee F, Wilson RH, Harper C, Patterson CC, McCallion K, Houston RF, et al. Influence of hospital and clinician workload on survival from colorectal cancer: cohort study. BMJ. 1999;318:1381–5.PubMedCrossRef
4.
go back to reference Boyle E, Timmons A, Al-Akash M, Kennedy AM, O’Grady H, Hill AD, et al. The management of rectal cancer in Ireland in 2007–room for improvement? Surgeon. 2011;9:179–86.PubMedCrossRef Boyle E, Timmons A, Al-Akash M, Kennedy AM, O’Grady H, Hill AD, et al. The management of rectal cancer in Ireland in 2007–room for improvement? Surgeon. 2011;9:179–86.PubMedCrossRef
5.
go back to reference Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341–52.PubMedCrossRef Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341–52.PubMedCrossRef
6.
go back to reference Hogan AM, Kennelly R, Winter DC. Volume-outcome analysis in rectal cancer: a plea for enquiry, evidence and evolution. Eur J Surg Oncol. 2009;35:111–2.PubMedCrossRef Hogan AM, Kennelly R, Winter DC. Volume-outcome analysis in rectal cancer: a plea for enquiry, evidence and evolution. Eur J Surg Oncol. 2009;35:111–2.PubMedCrossRef
7.
go back to reference Elferink MA, Krijnen P, Wouters MW, Lemmens VE, Jansen-Landheer ML, van de Velde CJ, et al. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010;36 Suppl 1:S74–82.PubMedCrossRef Elferink MA, Krijnen P, Wouters MW, Lemmens VE, Jansen-Landheer ML, van de Velde CJ, et al. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010;36 Suppl 1:S74–82.PubMedCrossRef
8.
go back to reference Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.PubMedCrossRef Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.PubMedCrossRef
9.
go back to reference Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–20.PubMedCrossRef Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–20.PubMedCrossRef
10.
go back to reference Simunovic M, Jacob S, Coates AJ, Vogt K, Moran BJ, Heald RJ, et al. Outcomes following a limited approach to radiotherapy in rectal cancer. Br J Surg. 2011;98:1483–8.PubMedCrossRef Simunovic M, Jacob S, Coates AJ, Vogt K, Moran BJ, Heald RJ, et al. Outcomes following a limited approach to radiotherapy in rectal cancer. Br J Surg. 2011;98:1483–8.PubMedCrossRef
11.
go back to reference Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253:711–9.PubMedCrossRef Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253:711–9.PubMedCrossRef
12.
go back to reference Gagliardi G, Pucciarelli S, Asteria CR, Infantino A, Romano G, Cola B, et al. A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol. 2010;14:229–35.PubMedCrossRef Gagliardi G, Pucciarelli S, Asteria CR, Infantino A, Romano G, Cola B, et al. A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol. 2010;14:229–35.PubMedCrossRef
13.
go back to reference Mroczkowski P, Ortiz H, Penninckx F, Påhlman L. European quality assurance programme in rectal cancer—are we ready to launch? Colorectal Dis. 2012;14:960–6.PubMedCrossRef Mroczkowski P, Ortiz H, Penninckx F, Påhlman L. European quality assurance programme in rectal cancer—are we ready to launch? Colorectal Dis. 2012;14:960–6.PubMedCrossRef
14.
go back to reference MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.CrossRef MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.CrossRef
15.
go back to reference Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479–82.PubMedCrossRef Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479–82.PubMedCrossRef
16.
go back to reference Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996–9.PubMedCrossRef Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996–9.PubMedCrossRef
17.
go back to reference Royal College of Radiologists. Recommendations for Cross-Sectional Imaging in Cancer Management. London: Royal College of Radiologists; 2006. Royal College of Radiologists. Recommendations for Cross-Sectional Imaging in Cancer Management. London: Royal College of Radiologists; 2006.
18.
go back to reference Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd ed. London: Association of Coloproctology of Great Britain and Ireland; 2007. Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd ed. London: Association of Coloproctology of Great Britain and Ireland; 2007.
19.
go back to reference Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon s specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;3:CD005391.PubMed Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon s specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;3:CD005391.PubMed
20.
go back to reference Killeen SD, O’Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389–402.PubMedCrossRef Killeen SD, O’Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389–402.PubMedCrossRef
21.
go back to reference Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93–6.PubMedCrossRef Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93–6.PubMedCrossRef
22.
go back to reference Leonard D, Penninckx F, Fieuws S, Jouret-Mourin A, Sempoux C, Jehaes C, et al. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg. 2010;252:982–8.PubMedCrossRef Leonard D, Penninckx F, Fieuws S, Jouret-Mourin A, Sempoux C, Jehaes C, et al. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg. 2010;252:982–8.PubMedCrossRef
23.
go back to reference Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group; Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.PubMedCrossRef Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group; Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.PubMedCrossRef
24.
go back to reference Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74–82.PubMedCrossRef Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74–82.PubMedCrossRef
25.
go back to reference West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97:588–99.PubMedCrossRef West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97:588–99.PubMedCrossRef
26.
go back to reference Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, et al. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol. 2011;29:4568–73.PubMedCrossRef Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, et al. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol. 2011;29:4568–73.PubMedCrossRef
27.
go back to reference Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer. 2007;97:1333–7.PubMedCrossRef Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer. 2007;97:1333–7.PubMedCrossRef
28.
go back to reference Benzoni E, Terrosu G, Intersimone D, Milan E, Chiaulon G, Bresadola V, et al. Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis. 2007;22:7–13.PubMedCrossRef Benzoni E, Terrosu G, Intersimone D, Milan E, Chiaulon G, Bresadola V, et al. Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis. 2007;22:7–13.PubMedCrossRef
29.
go back to reference Caudle AS, Kim HJ, Tepper JE, O’Neil BH, Lange LA, Goldberg RM, et al. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol. 2008;15:1931–6.PubMedCrossRef Caudle AS, Kim HJ, Tepper JE, O’Neil BH, Lange LA, Goldberg RM, et al. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol. 2008;15:1931–6.PubMedCrossRef
30.
go back to reference Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212–23.PubMedCrossRef Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212–23.PubMedCrossRef
31.
go back to reference Gunderson LL, Callister M, Marschke R, Young-Fadok T, Heppell J, Efron J. Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res. 2008;2:25–33.PubMed Gunderson LL, Callister M, Marschke R, Young-Fadok T, Heppell J, Efron J. Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res. 2008;2:25–33.PubMed
32.
go back to reference Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.PubMedCrossRef Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.PubMedCrossRef
33.
go back to reference Srinivasaiah N, Monson JR. Radiotherapy in rectal cancer: is it time for change? A qualitative analysis of the national questionnaire survey of members of ACPGBI on preliminary CRO7 results. Colorectal Dis. 2008;10:873–8.PubMedCrossRef Srinivasaiah N, Monson JR. Radiotherapy in rectal cancer: is it time for change? A qualitative analysis of the national questionnaire survey of members of ACPGBI on preliminary CRO7 results. Colorectal Dis. 2008;10:873–8.PubMedCrossRef
34.
go back to reference Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, et al. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006;24:361–9.PubMedCrossRef Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, et al. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006;24:361–9.PubMedCrossRef
Metadata
Title
Early Outcomes for Rectal Cancer Surgery in the Republic of Ireland Following a National Centralization Program
Authors
John P. Burke, PhD, MRCSI
J. Calvin Coffey, PhD, FRCSI
Emily Boyle, MD, MRCSI
Frank Keane, MCh, FRCSI
Deborah A. McNamara, MD, FRCSI
Publication date
01-10-2013
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 11/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3131-2

Other articles of this Issue 11/2013

Annals of Surgical Oncology 11/2013 Go to the issue